By
Leigh Hartman The United States is rejoining the Paris Agreement, renewing its commitment to partnering with other nations to tackle the global threat of climate change. After his January 20 inaugural address, President Biden signed
formal documentation returning the United States to the December 12, 2015, Paris Agreement, a critical framework for avoiding potentially disastrous consequences from climate ...
Read More»
By U.S. Embassy Tbilisi | 21 January, 2021 | Topics: Key Officials, News, News from Washington, President of the United States | Tags: climate change, innovation, President Biden, renewable energy
By
Noelani Kirschner U.S. embassies in Estonia, Latvia, Denmark and Lithuania partnered to virtually co-host the
48 for the Future “hackathon,” implemented by private partners Garage48 and Startup Wise Guys on December 3-6. The hackathon let participants design a mobile phone app or other tech solution to address the complexities of the post-COVID-19 economic recovery. More than 600 people from 70 ...
Read More»
By U.S. Embassy Tbilisi | 14 December, 2020 | Topics: Health Issues, News, Science & Tech | Tags: Coronavirus, health technologies, innovation, technology
The United States has launched a strategy to mobilize its vast resources to support global economic recovery after the COVID-19 pandemic. The U.S. Department of State’s
Global Economic Activity and Recovery (GEAR) strategy will support this broader effort by enabling food trade and security, deploying financial tools for economic recovery, supporting U.S. exporters and investors abroad, and helping restore international transportation and ...
Read More»
By U.S. Embassy Tbilisi | 2 December, 2020 | Topics: Economic Affairs, Health Issues, News | Tags: Coronavirus, Disease prevention and control, economic security, innovation, Trade
Two U.S.-supported COVID-19 vaccine candidates appear to be highly effective at preventing COVID-19, a major step in the United States’
historic push to end the global pandemic . Moderna announced November 16 that the Phase 3 clinical trial’s independent data and safety monitoring board had found the Massachusetts-based biotechnology company’s candidate vaccine is up to 94.5% effective in clinical trials. Pfizer, based ...
Read More»
By U.S. Embassy Tbilisi | 19 November, 2020 | Topics: Health Issues, News | Tags: Coronavirus, Disease prevention and control, Health Programs, innovation, science
A 14-year-old American student’s award-winning science project could offer insights into a potential treatment for COVID-19. Anika Chebrolu, an eighth-grader and aspiring medical researcher from Frisco, Texas, used computer modeling to pinpoint a molecule that can bind to the coronavirus that causes COVID-19 and inhibit its ability to infect people, according to news reports. Anika ...
Read More»
By U.S. Embassy Tbilisi | 18 November, 2020 | Topics: Health Issues, News, Science & Tech | Tags: Coronavirus, Disease prevention and control, innovation, science
The United States is helping people protect themselves from dangerous pollution with a new mobile phone app that provides accurate, up-to-date information on air quality in dozens of cities worldwide. The U.S. Department of State recently launched ZephAir, a mobile app that brings users a mix of air-quality data and health advisories. Users may adjust ...
Read More»
By U.S. Embassy Tbilisi | 18 November, 2020 | Topics: News, Science & Tech | Tags: clean air, health technologies, innovation, technology
As the world leader in technological innovation, the United States is working with international partners to advance a shared competitive edge. The White House October 15 released the first
National Strategy for Critical and Emerging Technologies , outlining how the United States will support and lead global innovation in fields ranging from artificial intelligence to advanced computing and space technologies. The National ...
Read More»
By U.S. Embassy Tbilisi | 10 November, 2020 | Topics: History, News | Tags: economic security, innovation, international security, science, technology
U.S. innovators have developed an antiviral drug that can be used to treat patients hospitalized with COVID-19, part of America’s wide-ranging response to the global pandemic. The U.S. Food and Drug Administration on October 22 approved Gilead Sciences’ antiviral remdesivir for adults and children older than 12 who are under hospital care for COVID-19. Remdesivir ...
Read More»
By U.S. Embassy Tbilisi | 5 November, 2020 | Topics: Health Issues, News | Tags: Coronavirus, Disease prevention and control, Health Programs, innovation
U.S. innovators are developing new computers to help solve the world’s most pressing problems. Do you need to know whether this year’s crop yields will provide enough food? What if an airline wants to quickly adjust routes to avoid severe storms and prevent delays? Quantum computers have the power to analyze and calculate data faster ...
Read More»
By U.S. Embassy Tbilisi | 28 October, 2020 | Topics: News, Science & Tech | Tags: business success, innovation, science, startup, technology
The Global Innovation Index ranks the United States as the highest-spending country on research and development. With research and development spending of more than a half-trillion dollars in a recent year, as reported by the National Science Foundation, U.S. labs have turned to the challenges posed by the new coronavirus. Private businesses do the lion’s ...
Read More»
By U.S. Embassy Tbilisi | 10 September, 2020 | Topics: Health Issues, News | Tags: Coronavirus, Disease prevention and control, innovation, science, technology
Researchers at the U.S. and Singapore–based company Avago spent more than 20 years developing technology to improve wireless communication. But an employee stole that technology to benefit the Chinese government. U.S. officials cited that theft as one example of the Chinese Communist Party’s (CCP) “expansive approach” to stealing technology and intellectual property. Its goal? To ...
Read More»
By U.S. Embassy Tbilisi | 19 August, 2020 | Topics: News, Science & Tech | Tags: China, innovation, international security, science, technology
(State Dept./D. Thompson) By
Lenore T. Adkins In the United States, reputable scientific journals set a high bar for scientists angling to publish their work, and for good reason. The journals don’t want to be duped into trumpeting bad science. Take
Science Immunology , one of several peer-reviewed journals published by the
American Association for the Advancement of Science , the world’s largest, multidisciplinary scientific society. (Note: ...
Read More»
By U.S. Embassy Tbilisi | 3 August, 2020 | Topics: News from Washington | Tags: China, innovation, science
Tracking COVID-19 with artificial intelligence (July 22) Artificial intelligence (AI) is becoming a powerful tool for tracking and treating COVID-19 in the U.S. and abroad. Several U.S. institutions are developing new AI technology or using preexisting technology to monitor and treat the new coronavirus. HealthMap, an AI application run by Boston Children’s Hospital, was launched ...
Read More»
By U.S. Embassy Tbilisi | 22 July, 2020 | Topics: Health Issues, News | Tags: Coronavirus, Disease prevention and control, Health Programs, innovation, science
U.S. company uses drones to deliver COVID-19 tests in Ghana (May 12) An American company based in California is using drones to transport COVID-19 tests between rural Ghana and two of the country’s main cities. Zipline International Inc. is one example of the many
private U.S. companies that are stepping forward to address the coronavirus crisis internationally. ...
Read More»
By U.S. Embassy Tbilisi | 12 May, 2020 | Topics: Health Issues, Human Rights, News | Tags: Coronavirus, Ghana, health technologies, innovation, technology
